Clinical Trial Update: Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone [Phase 3]

View source ↗

Summary

Phase 3 study comparing combination therapy with LdT (telbivudine) plus adefovir versus adefovir alone in hepatitis B was terminated, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir (adefovir)
• LdT (telbivudine)

Snippet

Sponsor: Novartis | Conditions: Hepatitis B | Phase 3 | Status: TERMINATED | Results posted: 2011-05-17